摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氯-5-氟苯酚 | 202982-70-5

中文名称
3-氯-5-氟苯酚
中文别名
——
英文名称
3-chloro-5-fluorophenol
英文别名
——
3-氯-5-氟苯酚化学式
CAS
202982-70-5
化学式
C6H4ClFO
mdl
——
分子量
146.549
InChiKey
ZMFBYTAAMHWQHD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    206.0±20.0 °C(Predicted)
  • 密度:
    1.408±0.06 g/cm3(Predicted)
  • 稳定性/保质期:

    避氧化物

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    8
  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R20/21/22
  • 海关编码:
    2908199090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335

SDS

SDS:7a75cc2e9e1b61d71378465d5abafc5b
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-Chloro-5-fluorophenol
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H314: Causes severe skin burns and eye damage
H318: Causes serious eye damage
H302: Harmful if swallowed
H312: Harmful in contact with skin
H411: Toxic to aquatic life with long lasting effects
H401: Toxic to aquatic life
P280: Wear protective gloves/protective clothing/eye protection/face protection
P273: Avoid release to the environment
P303+P361+P353: IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with
water/shower
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P310: Immediately call a POISON CENTER or doctor/physician

Section 3. Composition/information on ingredients.
Ingredient name: 3-Chloro-5-fluorophenol
CAS number: 202982-70-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H4ClFO
Molecular weight: 146.5

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN3265 Class: 8 Packing group: III
Proper shipping name: CORROSIVE LIQUID, ACIDIC, ORGANIC, N.O.S. (3-Chloro-5-fluorophenol)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-氯-5-氟苯酚聚合甲醛 作用下, 以48%的产率得到3-chloro-5-fluoro-4-(hydroxymethyl)phenol
    参考文献:
    名称:
    Novel piperazine derivatives
    摘要:
    本发明是一种具有公式(I)的化学化合物 1 或其药物可接受的盐、溶剂化物和酯,其中R 1 至R 4 ,A 1 ,A 2 ,m和n如说明书中所述。
    公开号:
    US20020143020A1
  • 作为产物:
    描述:
    3-氯-5-氟苯甲醚三溴化硼碳酸氢钠 作用下, 以 二氯甲烷 为溶剂, 反应 0.25h, 以88%的产率得到3-氯-5-氟苯酚
    参考文献:
    名称:
    WO2006/136924
    摘要:
    公开号:
  • 作为试剂:
    描述:
    1-溴-3-氯-5-氟苯叔丁基锂硼酸三甲酯过氧乙酸potassium bisulfitesodium hydroxide乙醚 、 Mg2SO4 、 3-氯-5-氟苯酚正庚烷溶剂黄146 作用下, 以 乙醚 为溶剂, 反应 18.0h, 生成 3-氯-5-氟苯酚
    参考文献:
    名称:
    Substituted amides
    摘要:
    结构式(I)的新型化合物是大麻素-1(CB1)受体的拮抗剂和/或反向激动剂,可用于治疗、预防和抑制由CB1受体介导的疾病。本发明的化合物可作为中枢作用药物用于治疗精神病、记忆障碍、认知障碍、偏头痛、神经病、神经炎症性疾病,包括多发性硬化症和格林-巴利综合症以及病毒性脑炎、脑血管意外和头部创伤的炎症后遗症、焦虑症、应激、癫痫、帕金森病、运动障碍和精神分裂症。这些化合物还可用于治疗物质滥用障碍、肥胖症或进食障碍,以及哮喘、便秘、慢性肠假性梗阻和肝硬化的治疗。
    公开号:
    US20040058820A1
点击查看最新优质反应信息

文献信息

  • 喹啉酮类化合物及其在药物中应用
    申请人:广东东阳光药业有限公司
    公开号:CN105384687B
    公开(公告)日:2018-05-01
    本发明涉及喹啉酮类化合物及其在药物中的应用,具体涉及一种新的喹啉酮类化合物及其药物组合物,以及所述化合物或所述药物组合物在制备药物中的用途;所述药物用于防护、处理、治疗或减轻患者HIF相关和/或EPO相关的疾病,其中,所述HIF相关和/或EPO相关的疾病包括贫血、血管疾病、心肌局部缺血、代谢障碍或伤口愈合等。
  • [EN] 1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS<br/>[FR] DÉRIVÉS D'AZÉTIDINE OU DE CYCLOBUTANE 1,3-DISUBSTITUÉS UTILISÉS COMME INHIBITEURS DE LA PROSTAGLANDINE D SYNTHASE HÉMATOPOÏÉTIQUE (H-PGDS)
    申请人:GLAXOSMITHKLINE IP DEV LTD
    公开号:WO2018069863A1
    公开(公告)日:2018-04-19
    A compound of formula (I), wherein R, R1, R2, R3, Y, Y1, a, X, and Z are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in the treatment of Duchenne Muscular Dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
    式(I)的化合物,其中R、R1、R2、R3、Y、Y1、a、X和Z的定义如本文所述。本发明的化合物是造血前列腺素D合成酶(H-PGDS)的抑制剂,可用于治疗杜兴氏肌肉萎缩症。因此,本发明进一步涉及包含本发明化合物的药物组合物。本发明还进一步涉及使用本发明化合物或包含本发明化合物的药物组合物来抑制H-PGDS活性和治疗相关疾病的方法。
  • [EN] TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES<br/>[FR] COMPOSÉS DE TÉTRAZOLINONE ET LEUR UTILISATION EN TANT QUE PESTICIDES
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2013162072A1
    公开(公告)日:2013-10-31
    The present invention provides a compound having an excellent efficacy for controlling pests. A tetrazolinone compound of a formula (1): [wherein R1 represents an C6-C16 aryl group, an C1-C12 alkyl group, or a C3-C12 cycloalkyl group, etc., which each optionally be substituted; R2, R3, R4 and R5 represent independently of each other a hydrogen atom, a halogen atom or an C1-C3 alkyl group, etc.; R6 represents an C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogen atom, a C1-C6 haloalkyl group, an C2-C6 alkenyl group, an C1-C6 alkoxy group, or a C1-C6 haloalkoxy group, etc.; R7, R8 and R9 represent independently of each other a hydrogen atom, a halogen atom, or an C1-C4 alkyl group, etc.; X represents an oxygen atom or a sulfur atom; and R10 represents an C1-C6 alkyl group, etc.] shows an excellent controlling efficacy on pests.
    本发明提供了一种具有优异杀虫效果的化合物。公式(1)的四唑酮化合物:[其中R1代表C6-C16芳基、C1-C12烷基或C3-C12环烷基等,每个都可以选择性地被取代;R2、R3、R4和R5分别独立地代表氢原子、卤素原子或C1-C3烷基等;R6代表C1-C6烷基、C3-C6环烷基、卤素原子、C1-C6卤代烷基、C2-C6烯基、C1-C6烷氧基或C1-C6卤代烷氧基等;R7、R8和R9分别独立地代表氢原子、卤素原子或C1-C4烷基等;X代表氧原子或原子;R10代表C1-C6烷基等]在杀虫方面表现出优异的控制效果。
  • [EN] ARYL ETHERS AND USES THEREOF<br/>[FR] ARYLÉTHERS ET UTILISATIONS DE CEUX-CI
    申请人:PELOTON THERAPEUTICS INC
    公开号:WO2015035223A1
    公开(公告)日:2015-03-12
    The present disclosure relates to HIF-2α inhibitors and methods of making and using them for treating cancer. Certain compounds were potent in HIF-2α scintillation proximity assay, luciferase assay, and VEGF ELISA assay, and led to tumor size reduction and regression in 786-O xenograft bearing mice in vivo.
    本公开涉及HIF-2α抑制剂及其制备和用于治疗癌症的方法。某些化合物在HIF-2α闪烁近距离法、荧光素酶法和VEGF ELISA法中表现出强效,导致786-O异种移植瘤小鼠体内肿瘤大小减小和回归。
  • [EN] IMIDAZOLIDINEDIONE DERIVATIVES<br/>[FR] DÉRIVÉS D'IMIDAZOLIDINEDIONE
    申请人:GLAXO GROUP LTD
    公开号:WO2011069951A1
    公开(公告)日:2011-06-16
    The invention provides a compound of formula (Ia), and pharmaceutically acceptable salts thereof. The invention also provides use of the compounds or salts as modulators of Kv3.1 and/or Kv3.2, and in the treatment of diseases or disorders where a modulator of Kv3.1 and/or Kv3.2 is required, such as depression and mood disorders, hearing disorders, schizopherenea, substance abuse disorders, sleep disorders or epilepsy.
    这项发明提供了化合物(Ia)及其药学上可接受的盐。该发明还提供了将这些化合物或盐用作Kv3.1和/或Kv3.2的调节剂,以及在需要Kv3.1和/或Kv3.2调节剂的疾病或紊乱的治疗中的用途,如抑郁症和情绪障碍、听觉障碍、精神分裂症、物质滥用障碍、睡眠障碍或癫痫病。
查看更多